BIOBIJOU Co.,Ltd. (KOSDAQ:489460)

Market Cap	133.14B
Revenue (ttm)	28.49B -3.9%
Net Income	4.15B -42.2%
EPS	298.00 -52.7%
Shares Out	15.04M
PE Ratio	29.70
Forward PE	n/a
Dividend	100.00 (1.18%)
Ex-Dividend Date	Dec 29, 2025

Volume	87,755
Average Volume	63,816
Open	8,380.00
Previous Close	8,370.00
Day's Range	8,380.00 - 8,740.00
52-Week Range	7,690.00 - 26,500.00
Beta	n/a
RSI	50.95
Earnings Date	May 14, 2026

About BIOBIJOU

BIOBIJOU Co.,Ltd. engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea. It offers cosmetic products which includes skin boosters which is used in treatment to improve skin condition using microneedle therapy system; medical devices include hyaluronic acid dermal fillers under the COLENA PREMIUM and CANDORLOV brand name; and pharmaceuticals, such as include botulinum toxin. It also exports its products to Iraq, the Dominican Republic, Turkey, China, Vietnam, Hong Kong, Russia, Malaysia,...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2018
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 489460

Financial Performance

In 2025, BIOBIJOU's revenue was 28.49 billion, a decrease of -3.86% compared to the previous year's 29.63 billion. Earnings were 4.15 billion, a decrease of -42.24%.